Literature DB >> 21106799

Detection of yellow fever 17D genome in urine.

Cristina Domingo, Sergio Yactayo, Edinam Agbenu, Maurice Demanou, Axel R Schulz, Katjana Daskalow, Matthias Niedrig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21106799      PMCID： PMC3043487          DOI： 10.1128/JCM.01775-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  18 in total

1.  Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Authors:  Thomas P Monath; Farshad Guirakhoo; Richard Nichols; Sutee Yoksan; Robert Schrader; Chris Murphy; Paul Blum; Stephen Woodward; Karen McCarthy; Danell Mathis; Casey Johnson; Philip Bedford
Journal:  J Infect Dis       Date:  2003-10-03       Impact factor: 5.226

2.  Human fatal yellow fever. Immunohistochemical detection of viral antigens in the liver, kidney and heart.

Authors:  T De Brito; S A Siqueira; R T Santos; E S Nassar; T L Coimbra; V A Alves
Journal:  Pathol Res Pract       Date:  1992-02       Impact factor: 3.250

3.  Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  J Erin Staples; Mark Gershman; Marc Fischer
Journal:  MMWR Recomm Rep       Date:  2010-07-30

Review 4.  Yellow fever: an update.

Authors:  T P Monath
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

5.  Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium.

Authors:  Hi-Gung Bae; Christian Drosten; Petra Emmerich; Robert Colebunders; Philippe Hantson; Stefan Pest; Muriel Parent; Herbert Schmitz; Marc-Aurel Warnat; Matthias Niedrig
Journal:  J Clin Virol       Date:  2005-01-15       Impact factor: 3.168

6.  Antigenuria in St. Louis encephalitis.

Authors:  J P Luby; F K Murphy; J N Gilliam; C Y Kang; R Frank
Journal:  Am J Trop Med Hyg       Date:  1980-03       Impact factor: 2.345

7.  Jungle yellow fever: clinical and laboratorial studies emphasizing viremia on a human case.

Authors:  E da S Nassar; E L Chamelet; T L Coimbra; L T de Souza; A Suzuki; I B Ferreira; M V da Silva; I M Rocco; A P Travassos da Rosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1995 Jul-Aug       Impact factor: 1.846

8.  Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection.

Authors:  B Reinhardt; R Jaspert; M Niedrig; C Kostner; J L'age-Stehr
Journal:  J Med Virol       Date:  1998-10       Impact factor: 2.327

9.  Viruria during acute Japanese encephalitis virus infection.

Authors:  A Mathur; N Khanna; R Kulshreshtha; S C Maitra; U C Chaturvedi
Journal:  Int J Exp Pathol       Date:  1995-04       Impact factor: 1.925

10.  West Nile virus detection in urine.

Authors:  Jessica H Tonry; Craig B Brown; Cecil B Cropp; Juliene K G Co; Shannon N Bennett; Vivek R Nerurkar; Timothy Kuberski; Duane J Gubler
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883
View more
  28 in total

1.  Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories.

Authors:  Cristina Domingo; Pranav Patel; Jasmin Yillah; Manfred Weidmann; Jairo A Méndez; Emmanuel Rivalyn Nakouné; Matthias Niedrig
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

2.  Detection of tick-borne encephalitis virus RNA in urine.

Authors:  Malin Veje; Marie Studahl; Peter Norberg; Anette Roth; Ulrike Möbius; Magnus Brink; Tomas Bergström
Journal:  J Clin Microbiol       Date:  2014-08-27       Impact factor: 5.948

3.  Urine as Sample Type for Molecular Diagnosis of Natural Yellow Fever Virus Infections.

Authors:  Chantal B E M Reusken; Marjolein Knoester; Corine GeurtsvanKessel; Marion Koopmans; Daan G Knapen; Wouter F W Bierman; Suzan Pas
Journal:  J Clin Microbiol       Date:  2017-08-30       Impact factor: 5.948

Review 4.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

5.  Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Antonio Carlos R Vallinoto; Francisco De Paula Pinheiro
Journal:  Hum Vaccin Immunother       Date:  2019-11-14       Impact factor: 3.452

Review 6.  Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat.

Authors:  Jesse J Waggoner; Alejandra Rojas; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

7.  Evaluation of two molecular methods for the detection of Yellow fever virus genome.

Authors:  Marcio R T Nunes; Gustavo Palacios; Keley N B Nunes; Samir M M Casseb; Lívia C Martins; Juarez A S Quaresma; Nazir Savji; W Ian Lipkin; Pedro F C Vasconcelos
Journal:  J Virol Methods       Date:  2011-03-17       Impact factor: 2.014

Review 8.  Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.

Authors:  Thomas P Monath; Stephen J Seligman; James S Robertson; Bruno Guy; Edward B Hayes; Richard C Condit; Jean Louis Excler; Lisa Marie Mac; Baevin Carbery; Robert T Chen
Journal:  Vaccine       Date:  2014-10-27       Impact factor: 3.641

9.  First international external quality assessment study on molecular and serological methods for yellow fever diagnosis.

Authors:  Cristina Domingo; Camille Escadafal; Leonid Rumer; Jairo A Méndez; Paquita García; Amadou A Sall; Anette Teichmann; Oliver Donoso-Mantke; Matthias Niedrig
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

Review 10.  Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2016-06-20       Impact factor: 5.683
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.